Lifecome Biochemistry Co.,Ltd. (SHE:002868)
China
· Delayed Price · Currency is CNY 23.95
+0.35 (1.48%)
Jun 4, 2025, 11:44 AM CST
Lifecome Biochemistry Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Operating Revenue | 649.37 | 489.93 | 308.72 | 343.29 | 307.62 | Upgrade
|
| Other Revenue | - | 17.07 | 21.14 | 20.09 | 0.52 | Upgrade
|
| Revenue | 649.37 | 507 | 329.85 | 363.39 | 308.15 | Upgrade
|
| Revenue Growth (YoY) | 28.08% | 53.71% | -9.23% | 17.93% | 1.44% | Upgrade
|
| Cost of Revenue | 703.7 | 611.75 | 381.36 | 311.55 | 216.43 | Upgrade
|
| Gross Profit | -54.33 | -104.74 | -51.51 | 51.84 | 91.71 | Upgrade
|
| Selling, General & Admin | 61.05 | 54.06 | 38.16 | 37.29 | 29.79 | Upgrade
|
| Research & Development | 35.56 | 27.53 | 21.82 | 24.82 | 19.91 | Upgrade
|
| Other Operating Expenses | 2.31 | 4.53 | 3.86 | 2.97 | 3.79 | Upgrade
|
| Operating Expenses | 98.88 | 87.39 | 65.19 | 65.8 | 52.54 | Upgrade
|
| Operating Income | -153.21 | -192.13 | -116.7 | -13.96 | 39.17 | Upgrade
|
| Interest Expense | -62.06 | -37.1 | -16.22 | -2.81 | -0.98 | Upgrade
|
| Interest & Investment Income | 9.4 | 11.55 | 0.18 | 0.83 | 13.28 | Upgrade
|
| Currency Exchange Gain (Loss) | - | -0.56 | 2.1 | -1.23 | -3.8 | Upgrade
|
| Other Non Operating Income (Expenses) | 2.04 | -1.31 | -0.23 | -0.13 | -0.42 | Upgrade
|
| EBT Excluding Unusual Items | -203.84 | -219.55 | -130.88 | -17.31 | 47.25 | Upgrade
|
| Impairment of Goodwill | - | -12.7 | - | - | - | Upgrade
|
| Gain (Loss) on Sale of Investments | - | - | -10.12 | -20.56 | -3.03 | Upgrade
|
| Gain (Loss) on Sale of Assets | 0.04 | -0.04 | - | 0.01 | 0.07 | Upgrade
|
| Asset Writedown | -224.34 | -12.15 | -6.25 | -0.22 | - | Upgrade
|
| Other Unusual Items | - | 3.55 | 13.14 | 5.73 | 4.15 | Upgrade
|
| Pretax Income | -428.15 | -240.89 | -134.11 | -32.35 | 48.44 | Upgrade
|
| Income Tax Expense | 17.83 | -18.28 | -11.39 | -5.91 | 5.51 | Upgrade
|
| Earnings From Continuing Operations | -445.98 | -222.62 | -122.72 | -26.44 | 42.94 | Upgrade
|
| Minority Interest in Earnings | 1.11 | 0.8 | 0.78 | 0.4 | 0.27 | Upgrade
|
| Net Income | -444.86 | -221.82 | -121.94 | -26.04 | 43.21 | Upgrade
|
| Net Income to Common | -444.86 | -221.82 | -121.94 | -26.04 | 43.21 | Upgrade
|
| Net Income Growth | - | - | - | - | -24.15% | Upgrade
|
| Shares Outstanding (Basic) | 156 | 154 | 154 | 153 | 154 | Upgrade
|
| Shares Outstanding (Diluted) | 156 | 154 | 154 | 153 | 154 | Upgrade
|
| Shares Change (YoY) | 0.98% | -0.20% | 0.75% | -0.72% | 0.23% | Upgrade
|
| EPS (Basic) | -2.86 | -1.44 | -0.79 | -0.17 | 0.28 | Upgrade
|
| EPS (Diluted) | -2.86 | -1.44 | -0.79 | -0.17 | 0.28 | Upgrade
|
| EPS Growth | - | - | - | - | -24.32% | Upgrade
|
| Free Cash Flow | 16.35 | -651.3 | -146.15 | -322 | -163.07 | Upgrade
|
| Free Cash Flow Per Share | 0.10 | -4.23 | -0.95 | -2.10 | -1.06 | Upgrade
|
| Dividend Per Share | - | - | - | - | 0.140 | Upgrade
|
| Dividend Growth | - | - | - | - | 7.03% | Upgrade
|
| Gross Margin | -8.37% | -20.66% | -15.62% | 14.27% | 29.76% | Upgrade
|
| Operating Margin | -23.59% | -37.90% | -35.38% | -3.84% | 12.71% | Upgrade
|
| Profit Margin | -68.51% | -43.75% | -36.97% | -7.17% | 14.02% | Upgrade
|
| Free Cash Flow Margin | 2.52% | -128.46% | -44.31% | -88.61% | -52.92% | Upgrade
|
| EBITDA | -56.34 | -123.11 | -52.61 | 19.91 | 69.63 | Upgrade
|
| EBITDA Margin | -8.68% | -24.28% | -15.95% | 5.48% | 22.60% | Upgrade
|
| D&A For EBITDA | 96.87 | 69.03 | 64.09 | 33.87 | 30.45 | Upgrade
|
| EBIT | -153.21 | -192.13 | -116.7 | -13.96 | 39.17 | Upgrade
|
| EBIT Margin | -23.59% | -37.90% | -35.38% | -3.84% | 12.71% | Upgrade
|
| Effective Tax Rate | - | - | - | - | 11.37% | Upgrade
|
| Revenue as Reported | 649.37 | 507 | 329.85 | 363.39 | 308.15 | Upgrade
|
| Advertising Expenses | - | 0.44 | 0.8 | 2.03 | 1.4 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.